APGEApogee Therapeutics, Inc.

$134.93

Who owns APGE

223 institutions reported holding APGE for 2026Q1, together 113% of the company, more than the 204 a quarter earlier.

223

Institutions reporting a position · as of 2026Q1 · up from 204 the quarter before

Shares held by institutions
79.0M

Shares held by institutions · 113% of the company · long US equity positions only, as reported on Form 13F

Reported value
$6.64B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
42 / 30

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
11
New positions
42
Positions exited
30
Added to
100
Reduced
51
Institutional ownership by quarter, 2023Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q122379.0M$6.64B
2025Q420469.8M$5.27B
2025Q317359.6M$2.37B
2025Q218057.8M$2.51B
2025Q116761.5M$2.30B
2024Q415657.9M$2.62B
2024Q313756.1M$3.29B
2024Q213754.1M$2.13B
2024Q113852.9M$3.52B
2023Q48541.8M$1.16B
2023Q37240.1M$849M
Largest reported holders, 2026Q1
HolderShares% of companyValue
T. Rowe Price Investment Management, Inc.10.3Mn/a$867M
FMR LLC9.3Mn/a$780M
Venrock Adviser, LLC8.5Mn/a$715M
WELLINGTON MANAGEMENT GROUP LLP4.4Mn/a$368M
BlackRock Inc.4.1Mn/a$344M
VANGUARD GROUP INC3.3Mn/a$280M
RTW INVESTMENTS, LP2.8Mn/a$234M
HENDERSON GROUP PLC2.4Mn/a$199M
STATE STREET CORP2.2Mn/a$182M
Driehaus Capital Management LLC1.9Mn/a$162M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…